BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9,067 | $8,515 | $7,860 | $7,278 |
| % Growth | 6.5% | 8.3% | 8% | – |
| Cost of Goods Sold | $3,497 | $3,429 | $3,265 | $3,155 |
| Gross Profit | $5,570 | $5,086 | $4,595 | $4,123 |
| % Margin | 61.4% | 59.7% | 58.5% | 56.7% |
| R&D Expenses | $1,432 | $1,337 | $1,245 | $1,397 |
| G&A Expenses | $0 | $1,577 | $1,388 | $3,545 |
| SG&A Expenses | $5,058 | $5,564 | $5,069 | $4,014 |
| Sales & Mktg Exp. | $0 | $3,987 | $3,681 | $469 |
| Other Operating Expenses | $0 | $0 | $0 | $399 |
| Operating Expenses | $6,490 | $6,901 | $6,314 | $5,810 |
| Operating Income | -$920 | -$1,815 | -$1,719 | -$1,687 |
| % Margin | -10.1% | -21.3% | -21.9% | -23.2% |
| Other Income/Exp. Net | -$1,530 | -$2,226 | -$581 | -$1,261 |
| Pre-Tax Income | -$2,450 | -$4,041 | -$2,300 | -$2,948 |
| Tax Expense | $63 | $39 | $38 | $8 |
| Net Income | -$2,513 | -$4,080 | -$2,338 | -$2,956 |
| % Margin | -27.7% | -47.9% | -29.7% | -40.6% |
| EPS | -0.14 | -0.24 | -0.13 | -0.17 |
| % Growth | 41.7% | -84.6% | 23.5% | – |
| EPS Diluted | -0.14 | -0.24 | -0.13 | -0.17 |
| Weighted Avg Shares Out | 17,425 | 17,328 | 17,328 | 17,328 |
| Weighted Avg Shares Out Dil | 17,425 | 17,328 | 17,328 | 17,328 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,530 | $2,226 | $579 | $1,261 |
| Depreciation & Amortization | $385 | $407 | $399 | $341 |
| EBITDA | -$535 | -$1,408 | -$1,320 | -$1,346 |
| % Margin | -5.9% | -16.5% | -16.8% | -18.5% |